Endoceutics Bioanalytical and Analytical Laboratories
Initially located at the Laboratory of Molecular Endocrinology at the CHUL Research Center in Quebec City, the analytical laboratory has been relocated and has expanded its equipment and operations at the Quebec Technology Park, also in Quebec City.
Endoceutics bioanalytical and analytical laboratories offer unique high-throughput, high quality analytical and bioanalytical services to the biopharmaceutical industry, biotechnology industry, research organizations as well as academic and government institutions. All operations are GLP compliant.
During the past three decades, Dr. Fernand Labrie, founder and CEO of Endoceutics and his team have developed treatments against cancers sensitive to sex steroids, especially prostate and breast cancer. In the recent past, Endoceutics has been pursuing the development of novel treatments using a non-estrogenic approach, namely prasterone or dehydroepiandrosterone (DHEA), an exogenous sex steroid precursor against vulvovaginal atrophy, sexual dysfunction and other problems of menopause, including osteoporosis.
Such research requires the most advanced technology to identify and measure steroids and other small molecular weight compounds and metabolites. This technology is based upon mass spectrometry which replaced the earlier immunoassay-based technology.